CJC 1295 (without DAC) CND2 2mg*10vials

CJC 1295 (DAC-free) CND2 2mg*10 vials is a high-purity, short-acting physiological growth hormone-releasing hormone (GHRH) analog research peptide, the basic version of the CND series of pulse-type products. Unlike DAC-modified long-acting variants, this non-DAC structure avoids albumin-binding modification, exhibiting natural metabolic clearance and precise short half-life pulse-release characteristics. Its precise 2mg dosage is optimized for physiological pulse GH/IGF-1 axis studies, short-cycle dose-response model construction, acute endocrine intervention validation, and safe baseline metabolic mechanism studies. It provides a pure, natural growth hormone secretion rhythm without causing long-term accumulation, making it a core baseline research material for exploring the physiological endocrine regulation and acute metabolic composition of growth hormone peptides.

Product Function and Research Value

In laboratory studies, DAC-free CJC 1295 CND2 accurately mimics the physiological pulse of endogenous GHRH, triggering acute, orderly growth hormone secretion and a transient, moderate increase in IGF-1. Because it does not contain DAC, it does not retain albumin, and excess peptides can be naturally and rapidly metabolized, avoiding long-term accumulation and continuous hormonal additive effects in the body. Its core research value lies in physiological pulsed anabolic metabolism, acute lipid metabolism activation, exploration of short-cycle tissue repair mechanisms, and verification of endocrine response baseline thresholds. Compared to long-acting DAC versions that produce continuous and stable stimulation, CND2 perfectly mimics the body's natural intermittent hormone release pattern, thus enabling more realistic physiological mechanism studies. Due to its mild acute intervention, minimal experimental interference, and no delayed metabolic burden, it is ideally suited for short-term gradient dosing experiments, acute endocrine phenotype observation, and safety baseline verification, providing highly realistic and reproducible physiological data for basic research on the growth hormone pathway.

Core Product Advantages

1. Pure Non-DAC Physiological Structure: Pure CJC 1295 peptide, unmodified by chain DAC drug affinity complexes, retaining natural molecular metabolic characteristics, without abnormal albumin binding, and restoring the true endocrine pulse rhythm of the human body. 2. Precise short half-life pulsatile effect: Naturally and rapidly metabolized and cleared, preventing hormone accumulation and overstimulation, solving the problem of the continuous additive effect of long-acting peptides, suitable for simulating the intermittent endocrine regulation of daily physiological processes.

3. 2mg low-dose safety baseline specification: Professional entry-level low-concentration design, suitable for short-cycle acute experiments, effectively avoiding model tolerance, endocrine desensitization, and physiological stress caused by high-dose long-acting interventions, ensuring a safe and controllable experimental process.

4. Ultra-pure low-interference physiological regulation: Highly selectively targets the GHRH-GH-IGF-1 pathway, triggering orderly physiological secretion without interfering with cortisol, prolactin, and other stress hormones. Non-cumulative characteristics ensure clear and intuitive acute experimental procedures.

5. Pharmaceutical-grade lyophilized quality: Aseptic vacuum lyophilization process locks in the complete activity of the peptides. Each batch of product undergoes rigorous HPLC purity testing and comes with an official COA certificate. Aseptic integrated packaging of 10 vials, suitable for basic physiological research, short-term endocrinology projects in universities, and bulk wholesale purchases.

CJC 1295 (DAC-free) CND2 2mg*10 vials is a high-purity, short-acting physiological growth hormone-releasing hormone (GHRH) analog research peptide, the basic version of the CND series of pulsatile formulations. Unlike DAC-modified long-acting formulations, this product uses a **DAC-free natural structure**, eliminating the albumin-binding modification characteristics and exhibiting the typical features of natural metabolic clearance, short half-life, and pulsatile release. This precisely formulated 2mg low-dose formulation is suitable for studies of the physiological pulsatile GH/IGF-1 axis, the construction of short-cycle dose-response models, the validation of acute endocrine interventions, and the exploration of basic metabolic mechanisms. It does not accumulate in the body for a long time, and its hormone release is closely synchronized with natural physiological rhythms, making it a core research foundation for studying **real physiological endocrine regulation and acute metabolism of in vivo components** in GH peptides.

Core uses and research value of the peptide: In research experiments, DAC-free CJC 1295 CND2 can accurately simulate the physiological effects of endogenous GHRH.